Cedars Sinai Health Ventures

Cedars Sinai Health Ventures is the corporate venture arm of Cedars-Sinai Medical Center in Los Angeles, writing checks of $1M to $5M at Series A through Series C. The fund invests in companies whose products plausibly intersect with Cedars-Sinai’s clinical and operational activity, which means founders are pitching investors who can pilot, validate, or scrutinize their technology inside one of the largest academic medical centers on the West Coast. That access matters more than the dollar size of the check.

The thesis covers digital health, health IT and healthcare software, and care delivery and tech-enabled services. The fund is particularly interested in companies that improve clinical workflows, expand access to specialty care, deploy AI in clinical and operational contexts, and address measurable cost or quality problems within US health systems. The portfolio reflects a bias toward companies that can prove value inside an academic medical center and then scale to other systems, which means founders should be ready for granular questions about implementation, change management, and clinical workflow integration during diligence.

Check sizes of $1M to $5M place the fund as a participating investor in Series A through Series C rounds rather than a lead. The geographic focus is the United States, with most investments in companies selling into US providers, though the fund will look at international companies with a credible US commercialization plan. Cedars-Sinai exposure can also include access to a clinical pilot or validation study, which is often more valuable to a digital health company than the capital itself. Founders should expect a diligence process that includes input from clinical and operational leaders.

The team brings together investors with venture, operating, and clinical backgrounds, working closely with Cedars-Sinai’s clinical leadership and innovation teams. That structure means portfolio companies can access subject-matter experts inside the system for product feedback, clinical advisory work, and pilot design, in addition to the standard set of venture services around fundraising and recruiting.

Cedars Sinai Health Ventures’ working style is collaborative and operator-friendly. The fund typically takes board observer seats and engages on commercial strategy, particularly around how to sell into health systems and how to design pilots that produce convincing evidence. The fund has co-invested with traditional venture firms and other health system venture arms, and it has supported portfolio companies through subsequent rounds and commercial expansion. Founders building digital health, clinical software, or tech-enabled services that need an academic medical center as both validator and customer, and who want a strategic co-investor without the structural rigidity of a pure CVC, will find this fund a useful addition to a syndicate. Founders selling primarily to consumers or non-provider buyers will find less alignment.